Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
000514 Chong Qing Yukaifa
- 4.57
- +0.42+10.12%
Not Open Apr 24 15:00 CST
3.86BMarket Cap-33.85P/E (TTM)
4.57High4.14Low381.77KlotVolume4.17Open4.15Pre Close170.86MTurnover4.53%Turnover RatioLossP/E (Static)843.77MShares6.1152wk High1.06P/B3.86BFloat Cap2.9152wk Low4.57Limit Up843.77MShs Float17.05Historical High3.74Limit Down10.36%Amplitude0.21Historical Low0.01Dividend TTM4.48Avg Price237.63KlotAsk0.26%Div YieldTTM100Lot Size141.87KlotBid
Chong Qing Yukaifa Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 3.13%576.06M | -32.90%677.42M | 4.73%1.09B | -28.65%775.99M | -36.89%558.59M | -22.49%1.01B | -4.68%1.04B | -1.00%1.09B | -28.42%885.11M | -10.20%1.3B |
| Transactional financial assets | 48.28%181.5M | 36.00%163.2M | 39.83%150.6M | 26.98%139.8M | 15.58%122.4M | 12.04%120M | -2.97%107.7M | -7.79%110.1M | -8.31%105.9M | -7.51%107.1M |
| Notes receivable and accounts receivable | -53.56%231.23M | 1,955.01%247.55M | 1,864.25%243.75M | 1,796.86%241.27M | 1,517.09%497.96M | -83.49%12.05M | -89.70%12.41M | -89.35%12.72M | -73.85%30.79M | 459.46%72.95M |
| -Notes receivable | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| -Accounts receivable | -53.56%231.23M | 1,955.01%247.55M | 1,864.25%243.75M | 1,796.86%241.27M | 1,517.09%497.96M | -83.49%12.05M | -89.70%12.41M | -89.35%12.72M | -73.85%30.79M | 459.46%72.95M |
| Other receivables (including interest and dividends) | -8.71%63.5M | 24.80%70.07M | 20.79%67.38M | 26.38%68.6M | 151.36%69.56M | -93.14%56.15M | 104.71%55.79M | 103.08%54.28M | 3.32%27.67M | 2,184.47%818.88M |
| -Dividend receivable | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| -Accrued interest receivable | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Other receivable | ---- | --70.07M | 20.79%67.38M | ---- | ---- | ---- | 104.71%55.79M | ---- | 3.32%27.67M | ---- |
| Contractual assets | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Advance payment | -99.95%373.92K | -43.53%780.73K | -17.40%856.85K | 16.15%1.19M | 77,369.72%798.59M | -53.21%1.38M | 22.65%1.04M | 4.33%1.02M | 30.52%1.03M | 13.79%2.95M |
| Inventories | -3.85%3.78B | -12.91%3.83B | -11.73%3.84B | -9.08%3.89B | -6.63%3.93B | 1.04%4.4B | -25.35%4.35B | -24.06%4.28B | -23.96%4.21B | -23.10%4.35B |
| Receivable financing | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Assets held for sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Non-current assets due within one year | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Other current assets | 40.15%204.81M | -4.13%195.57M | 3.07%194.47M | 10.81%190.48M | -5.03%146.14M | -5.69%204M | -3.98%188.68M | -6.00%171.89M | 2.44%153.87M | 7.92%216.3M |
| Total current assets | -17.74%5.04B | -10.62%5.18B | -2.94%5.58B | -7.16%5.31B | 13.09%6.13B | -15.61%5.8B | -21.94%5.75B | -20.41%5.72B | -24.63%5.42B | -8.09%6.87B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Other equity investment | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Other non-current financial assets | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Investment real estate | 327.82%1.02B | 324.42%1.02B | 253.16%1.03B | 241.76%1B | -19.27%239.48M | -19.01%241.43M | -3.39%290.58M | -3.11%293.99M | -3.08%296.65M | -5.48%298.11M |
| Long-term equity investment | -0.58%807.61M | -0.45%809.9M | -0.47%811.55M | -0.54%810.93M | -0.48%812.3M | 65,855.96%813.57M | --815.39M | --815.32M | --816.23M | --1.23M |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Fixed assets | 6.34%598.66M | ---- | -4.64%549.87M | ---- | -4.68%562.97M | ---- | -4.61%576.63M | ---- | -4.49%590.63M | ---- |
| Constru in process | ---- | ---- | --59.44M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Productive biological assets | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Oil and gas assets | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Intangible assets | -19.51%122.06M | -18.54%129.26M | -17.71%136.72M | -16.96%144.17M | -16.17%151.64M | -15.75%158.68M | -15.15%166.15M | -14.55%173.61M | -14.12%180.89M | -13.63%188.35M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Long deferred expense | --832.96K | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Deferred tax assets | 62.59%171.31M | 94.40%151.51M | 91.81%140.53M | 59.49%119.95M | 60.32%105.36M | -5.81%77.94M | -9.96%73.27M | 14.22%75.21M | 10.42%65.72M | 9.39%82.75M |
| Usufruct assets | ---- | --0 | ---- | ---- | ---- | -80.00%383.91K | -66.67%767.82K | -57.14%1.15M | -50.00%1.54M | -44.44%1.92M |
| Other non current assets | 0.00%35K | 0.00%35K | 0.00%35K | 0.00%35K | 0.00%35K | 0.00%35K | 0.00%35K | 0.00%35K | 0.00%35K | 0.00%35K |
| Total non current assets | 41.41%2.73B | 42.05%2.72B | 41.69%2.72B | 38.63%2.69B | -1.26%1.93B | 63.69%1.92B | 62.29%1.92B | 63.71%1.94B | 62.95%1.95B | -5.50%1.17B |
| Total assets | -3.59%7.77B | 2.46%7.9B | 8.23%8.31B | 4.45%8.01B | 9.29%8.06B | -4.07%7.71B | -10.28%7.68B | -8.49%7.66B | -12.13%7.37B | -7.72%8.04B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Notes payable and accounts payable | -8.31%732.22M | 46.01%722.91M | 39.66%715.73M | 37.95%729.56M | 30.54%798.55M | 25.03%495.1M | 25.16%512.48M | 32.39%528.85M | 19.90%611.73M | 23.29%395.98M |
| -Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| -Accounts payable | -8.31%732.22M | 46.01%722.91M | 39.66%715.73M | 37.95%729.56M | 30.54%798.55M | 25.03%495.1M | 25.16%512.48M | 32.39%528.85M | 19.90%611.73M | 23.29%395.98M |
| Contract liabilities | 52.00%62.89M | -91.49%45.22M | -88.47%53.71M | -86.93%52.28M | -85.67%41.38M | -47.58%531.49M | -50.32%465.85M | -47.57%399.85M | -58.79%288.68M | -18.28%1.01B |
| Advance receipts | -11.95%6.01M | -74.43%5.84M | -54.32%9.53M | -65.67%7.91M | -73.52%6.83M | -4.25%22.84M | -7.26%20.86M | -5.42%23.05M | 11.62%25.8M | 4.31%23.85M |
| Salaries payable | -55.97%10.3M | 17.66%7.02M | 32.30%8.05M | 7.22%6.73M | -25.82%23.39M | 0.62%5.96M | 2.67%6.08M | -7.01%6.27M | 2.51%31.53M | -16.34%5.93M |
| Taxs payable | -77.66%22.67M | 16.02%31.21M | 4.49%26.48M | 125.32%97.27M | 122.06%101.49M | -21.44%26.9M | -17.87%25.35M | -21.10%43.17M | -48.43%45.7M | 37.75%34.24M |
| Other payable (including interest and dividends) | -12.35%1.3B | 21.89%1.46B | 25.59%1.5B | 24.05%1.48B | 54.69%1.48B | 0.91%1.2B | -26.41%1.2B | -26.13%1.19B | -42.38%959.82M | -28.56%1.19B |
| -Interest payable | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Dividend payable | ---- | --0 | --10.13M | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Other payable | ---- | --1.46B | 24.74%1.49B | ---- | ---- | ---- | -25.63%1.2B | ---- | ---- | ---- |
| Hold and for sell liabilities | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non current liabilities due within one year | -56.09%200.87M | -59.97%236.79M | 97.30%619.22M | -5.49%455.05M | 7.49%457.45M | 157.08%591.49M | -25.46%313.85M | 15.69%481.48M | 28.57%425.56M | -46.86%230.08M |
| Other current liabilities | 65.44%4.99M | -93.06%3.32M | -90.39%4.03M | -89.40%3.81M | -88.38%3.02M | -47.59%47.83M | -50.32%41.92M | -47.57%35.99M | -58.79%25.98M | -18.01%91.25M |
| Total current liabilities | -19.73%2.34B | -13.92%2.51B | 13.80%2.94B | 4.47%2.83B | 20.79%2.92B | -2.11%2.92B | -26.99%2.58B | -19.00%2.71B | -29.25%2.41B | -21.98%2.98B |
| Current liabilities | ||||||||||
| Long term loan | 69.40%652.15M | 174.89%691.75M | 276.02%663.52M | 1,343.02%439.12M | 2,471.14%384.98M | -18.48%251.65M | -36.15%176.46M | -87.72%30.43M | -91.85%14.97M | -8.52%308.7M |
| Bonds payable | 0.00%330M | 0.00%330M | -53.46%330M | -53.46%330M | -53.46%330M | -53.46%330M | 0.00%709M | 0.00%709M | 0.00%709M | 0.00%709M |
| Preferred stock | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Perpetual Debt | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Long term salaries pay | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Estimate liabilities | --172.43K | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | 52.33%3.37M |
| Deferred tax liabilities | 15.45%100.14M | 26.66%95.57M | 27.69%92.42M | 26.36%91.09M | 21.44%86.74M | 36.07%75.45M | 28.27%72.38M | 27.76%72.09M | 28.80%71.42M | 48.76%55.45M |
| Long term deferred income | -0.03%548.18K | -0.44%548.36K | -0.44%548.36K | -0.44%548.36K | -0.44%548.36K | -0.28%550.76K | -0.34%550.76K | -0.60%550.76K | -1.27%550.76K | -1.12%552.3K |
| Lease liabilities | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | -49.12%1.77M |
| Other non current liabilities | 24.07%2.63M | 5.41%2.19M | 8.77%2.26M | 38.33%2.88M | -6.20%2.12M | -48.39%2.08M | -20.91%2.08M | -10.44%2.08M | -2.76%2.26M | -55.36%4.03M |
| Total non current liabilities | 34.97%1.09B | 69.78%1.12B | 13.36%1.09B | 6.08%863.64M | 0.77%804.39M | -39.08%659.73M | -8.53%960.46M | -20.24%814.15M | -16.62%798.2M | -1.47%1.08B |
| Total liabilities | -7.91%3.43B | 1.50%3.63B | 13.68%4.03B | 4.84%3.7B | 15.82%3.72B | -11.95%3.58B | -22.76%3.54B | -19.29%3.53B | -26.48%3.21B | -17.40%4.07B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M | 0.00%843.77M |
| Other equity instruments | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| -Equity of prefer stock | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Equity of Perpetual debt | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Capital reserve funds | 0.49%1.2B | 0.08%1.19B | 0.08%1.19B | 0.08%1.19B | 0.08%1.19B | 0.00%1.19B | 0.00%1.19B | 0.03%1.19B | 0.03%1.19B | 0.10%1.19B |
| Surplus reserve funds | 0.00%205.29M | 4.91%205.29M | 4.91%205.29M | 4.91%205.29M | 4.91%205.29M | 7.19%195.69M | 7.19%195.69M | 7.19%195.69M | 7.19%195.69M | 8.88%182.57M |
| Retained profit | -8.22%1.38B | 3.24%1.45B | 4.10%1.47B | 5.19%1.48B | 5.55%1.51B | 12.06%1.41B | 12.61%1.41B | 9.73%1.41B | 10.25%1.43B | 11.46%1.26B |
| Less:Treasury stock | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other composite income | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Ordinary risk reserve funds | ---- | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | --0 |
| Specific reserves | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 |
| Shareholders equity without minority interests | -3.15%3.63B | 1.54%3.69B | 1.88%3.71B | 2.30%3.72B | 2.45%3.75B | 4.74%3.64B | 4.92%3.64B | 3.95%3.64B | 4.17%3.66B | 4.36%3.47B |
| Minority interests | 21.08%708.12M | 16.06%575.29M | 15.96%575.64M | 17.39%584.42M | 17.39%584.82M | -1.16%495.67M | -1.26%496.4M | -1.32%497.86M | -1.21%498.19M | 8.49%501.47M |
| Total shareholder equity | 0.12%4.34B | 3.29%4.27B | 3.57%4.28B | 4.12%4.31B | 4.24%4.33B | 4.00%4.13B | 4.14%4.13B | 3.29%4.14B | 3.49%4.16B | 4.86%3.97B |
| Total liabilityies and equity | -3.59%7.77B | 2.46%7.9B | 8.23%8.31B | 4.45%8.01B | 9.29%8.06B | -4.07%7.71B | -10.28%7.68B | -8.49%7.66B | -12.13%7.37B | -7.72%8.04B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Chongqing Kanghua Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Chongqing Kanghua Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Chongqing Kanghua Certified Public Accountants Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs